H. Yoshida et al., Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer, INT J ONCOL, 13(6), 1998, pp. 1141-1146
The nm23 gene was originally identified by differential hybridization of me
tastatic murine melanoma cell lines. Some experimental studies demonstrated
a significantly low metastatic potential of melanoma cell lines transfecte
d with the nm23 gene. In this study, we clarified the relationship between
intracellular nm23-immunoreactivity and lymph nodal status of human breast
cancer. We analyzed 82 surgically removed breast tumors including 67 invasi
ve carcinomas (ductal, lobular and mucinous carcinomas). The nm23 expressio
n was diffusely positive in the benign tumors and non-invasive carcinomas.
Of the invasive ductal carcinomas, lymph node metastasis was found in 67.7%
(21/31) of the focally positive/negative cases and in 18.2% (4/22) of the
diffusely positive cases (p<0.001). Immunohistochemically, advanced margins
of invasive carcinomas with lymph node metastasis were shown to be negativ
e for nm23 expression, while intraductal carcinoma components were positive
. This observation suggested that focally positive/ negative nm23 expressio
n can be a predictor of lymph node metastasis of invasive ductal breast car
cinoma.